Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

This company has been marked as potentially delisted and may not be actively trading.

XORTX Therapeutics (XRTX) Short Interest Ratio & Short Volume

XORTX Therapeutics logo
Compare

XORTX Therapeutics Short Interest Data

XORTX Therapeutics (XRTX) has a short interest of 59,700 shares, representing 1.65% of the float (the number of shares available for trading by the public). This marks a -62.76% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 92,848 shares to cover all short positions.

Current Short Interest
59,700 shares
Previous Short Interest
160,300 shares
Change Vs. Previous Month
-62.76%
Dollar Volume Sold Short
$43.94 thousand
Short Interest Ratio
0.6 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
5,210,000 shares
Float Size
3,620,000 shares
Short Percent of Float
1.65%
Today's Trading Volume
106,038 shares
Average Trading Volume
92,848 shares
Today's Volume Vs. Average
114%
Short Selling XORTX Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for XORTX Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

XRTX Short Interest Over Time

XRTX Days to Cover Over Time

XRTX Percentage of Float Shorted Over Time

XORTX Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202559,700 shares $43.94 thousand -62.8%1.7%0.6 $0.74
7/15/2025160,300 shares $139.46 thousand -99.3%4.4%1.5 $0.87
6/30/202523,780,000 shares $22.59 million +849,185.7%674.2%3.8 $0.95
6/15/20252,800 shares $2.48 thousand -75.9%0.1%0.1 $0.89
5/31/202511,600 shares $10.90 thousand +36.5%0.3%0.3 $0.94
5/15/20258,500 shares $8.41 thousand -63.5%0.2%0.2 $0.99
4/30/202523,300 shares $23.88 thousand -26.0%0.6%0.4 $1.03
4/15/202531,500 shares $29.30 thousand -7.6%0.9%0.6 $0.93
3/31/202534,100 shares $33.08 thousand +37.5%0.9%0.3 $0.97
3/15/202524,800 shares $25.05 thousand -64.6%0.7%0.2 $1.01
2/28/202570,100 shares $74.31 thousand +162.6%2.1%0.6 $1.06
2/15/202526,700 shares $24.03 thousand +9.0%0.8%0.2 $0.90
1/31/202524,500 shares $23.28 thousand -73.6%0.7%0.2 $0.95
1/15/202592,900 shares $117.98 thousand +3,340.7%2.8%0.9 $1.27
12/31/20242,700 shares $3.17 thousand +145.5%0.1%0 $1.18
12/15/20241,100 shares $1.31 thousand -57.7%0.0%0 $1.19
11/30/20242,600 shares $3.30 thousand -29.7%0.1%0 $1.27
11/15/20243,700 shares $4.81 thousand +68.2%0.1%0 $1.30
10/31/20242,200 shares $3.11 thousand +450.0%0.1%0 $1.42
10/15/2024400 shares $748.00 -98.7%0.0%0 $1.87
9/30/202431,300 shares $51.33 thousand -53.8%1.2%0 $1.64
9/15/202467,800 shares $120.01 thousand -94.5%2.5%0 $1.77
8/31/20241,230,000 shares $2.58 million +245,900.0%45.7%0.4 $2.10
8/15/2024500 shares $745.00 +400.0%0.0%0 $1.49
7/31/2024100 shares $173.00 -99.9%N/A0 $1.73
7/15/202490,900 shares $181.80 thousand +4,031.8%3.4%1.5 $2.00
6/30/20242,200 shares $4.18 thousand +29.4%0.1%0.2 $1.90
6/15/20241,700 shares $3.54 thousand -26.1%0.1%0.1 $2.08
5/31/20242,300 shares $5.80 thousand -32.4%0.1%0.1 $2.52
5/15/20243,400 shares $8.50 thousand -61.4%0.2%0.1 $2.50
4/30/20248,800 shares $22.44 thousand +3.5%0.5%0.2 $2.55
4/15/20248,500 shares $27.37 thousand -59.7%0.5%0.2 $3.22
3/31/202421,100 shares $78.07 thousand +101.0%1.2%0.4 $3.70
3/15/202410,500 shares $54.39 thousand +483.3%0.6%0.2 $5.18
2/29/20241,800 shares $5.47 thousand -78.1%0.1%0 $3.04
2/15/20248,200 shares $19.43 thousand +192.9%0.5%0.3 $2.37
1/31/20242,800 shares $6.94 thousand -67.4%0.2%0.1 $2.48
1/15/20248,600 shares $22.27 thousand +79.2%0.5%0 $2.59
12/31/20234,800 shares $11.09 thousand -68.6%1.6%0 $2.31
12/15/202315,300 shares $37.94 thousand -25.4%3.5%0.1 $2.48
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)

The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.

See his full breakdown of the seven stocks to own now
11/30/202320,500 shares $50.02 thousand +79.8%10.1%0.1 $2.44
11/15/202311,400 shares $27.59 thousand -33.3%5.6%0.1 $2.42
10/31/202317,100 shares $46.94 thousand -56.8%0.1%0 $2.75
10/15/202339,600 shares $11.92 thousand +142.9%0.2%0 $0.30
9/30/202316,300 shares $9.78 thousand -27.2%0.1%0.3 $0.60
9/15/202322,400 shares $14.78 thousand -35.5%0.1%0.5 $0.66
8/31/202334,700 shares $23.25 thousand +17.6%0.2%0.8 $0.67
8/15/202329,500 shares $18.15 thousand +64.8%0.2%0.7 $0.62
7/31/202317,900 shares $11.81 thousand +155.7%0.1%0.4 $0.66
7/15/20237,000 shares $4.48 thousand -76.9%0.0%0.1 $0.64
6/30/202330,300 shares $19.70 thousand -41.1%0.2%0.4 $0.65
6/15/202351,400 shares $32.90 thousand -13.9%0.3%0.6 $0.64
5/31/202359,700 shares $39.85 thousand +11.4%0.4%0.7 $0.67
5/15/202353,600 shares $36.77 thousand -7.9%0.3%0.5 $0.69
4/30/202358,200 shares $37.28 thousand -10.9%0.4%0.5 $0.64
4/15/202365,300 shares $47.60 thousand -19.3%0.4%0.3 $0.73
3/31/202380,900 shares $37.63 thousand -10.6%0.5%0.1 $0.47
3/15/202390,500 shares $46.61 thousand -29.6%0.7%0.1 $0.52
2/28/2023128,600 shares $75.75 thousand -10.5%1.0%0.2 $0.59
2/15/2023143,700 shares $84.93 thousand -15.4%1.1%0.2 $0.59
1/31/2023169,900 shares $100.24 thousand +14.8%1.3%0.2 $0.59
1/15/2023148,000 shares $114.06 thousand -2.3%1.2%0.2 $0.77
12/30/2022151,400 shares $122.33 thousand -7.2%1.2%6.4 $0.81
12/15/2022163,100 shares $136.03 thousand -4.0%1.3%5.1 $0.83
11/30/2022169,800 shares $147.73 thousand -4.1%1.4%3.8 $0.87
11/15/2022177,100 shares $159.57 thousand -11.9%1.4%3.6 $0.90
10/31/2022200,900 shares $169.76 thousand -1.7%1.8%1.6 $0.85
10/15/2022204,400 shares $169.65 thousand -52.6%1.8%1.6 $0.83
9/30/2022430,900 shares $521.39 thousand +56.9%3.8%0.9 $1.21
9/15/2022274,600 shares $359.73 thousand -5.4%2.4%0.6 $1.31
8/31/2022290,300 shares $391.91 thousand +108.6%2.6%0.6 $1.35
8/15/2022139,200 shares $210.19 thousand -4.9%1.2%0.3 $1.51
7/31/2022146,400 shares $199.10 thousand -78.1%1.3%0.4 $1.36
7/15/2022668,600 shares $1.14 million +4,327.8%5.9%1.4 $1.70
6/30/202215,100 shares $21.29 thousand -11.2%0.1%0.1 $1.41
6/15/202217,000 shares $24.65 thousand -16.3%0.2%0.1 $1.45
5/31/202220,300 shares $25.98 thousand -56.2%0.2%0.1 $1.28
5/15/202246,300 shares $70.38 thousand +282.6%0.4%0.2 $1.52
4/30/202212,100 shares $15.73 thousand -20.9%0.1%0.1 $1.30
4/15/202215,300 shares $28.84 thousand -81.7%0.1%0.2 $1.89
3/31/202283,500 shares $162.83 thousand +140.6%0.7%0.9 $1.95
3/15/202234,700 shares $42.33 thousand -16.6%0.3%0.4 $1.22
2/28/202241,600 shares $58.66 thousand -5.7%0.4%0.9 $1.41
2/15/202244,100 shares $70.56 thousand +3.8%0.4%0.8 $1.60
1/31/202242,500 shares $65.45 thousand +112.5%0.4%0.5 $1.54
1/15/202220,000 shares $39.40 thousand -60.0%0.2%0 $1.97
12/31/202150,000 shares $102.50 thousand No Change0.4%0 $2.05

XRTX Short Interest - Frequently Asked Questions

What is XORTX Therapeutics' current short interest?

Short interest is the volume of XORTX Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 59,700 shares of XRTX short. 1.65% of XORTX Therapeutics' shares are currently sold short. Learn More on XORTX Therapeutics' current short interest.

What is a good short interest ratio for XORTX Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XRTX shares currently have a short interest ratio of 1.0. Learn More on XORTX Therapeutics's short interest ratio.

What is a good short interest percentage for XORTX Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.65% of XORTX Therapeutics' floating shares are currently sold short.

Is XORTX Therapeutics' short interest increasing or decreasing?

XORTX Therapeutics saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 59,700 shares, a decline of 62.8% from the previous total of 160,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is XORTX Therapeutics' float size?

XORTX Therapeutics currently has issued a total of 5,210,000 shares. Some of XORTX Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. XORTX Therapeutics currently has a public float of 3,620,000 shares.

How does XORTX Therapeutics' short interest compare to its competitors?

1.65% of XORTX Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "med - drugs" compare to XORTX Therapeutics: Citius Pharmaceuticals, Inc. (7.31%), Marker Therapeutics, Inc. (6.37%), Incannex Healthcare Inc. (9.86%), ProPhase Labs, Inc. (0.36%), Carisma Therapeutics Inc. (2.03%), TherapeuticsMD, Inc. (0.18%), Ernexa Therapeutics Inc. (2.09%), Phio Pharmaceuticals Corp. (15.12%), BioVie Inc. (8.15%), Lyra Therapeutics, Inc. (2.95%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short XORTX Therapeutics stock?

Short selling XRTX is an investing strategy that aims to generate trading profit from XORTX Therapeutics as its price is falling. XRTX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against XORTX Therapeutics?

A short squeeze for XORTX Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XRTX, which in turn drives the price of the stock up even further.

How often is XORTX Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XRTX, twice per month. The most recent reporting period available is July, 31 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:XRTX) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
Altucher: It Looks Like My Trump prediction is coming true
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...
Paradigm Press | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored